Clinical trial
Open access
Oct 2026
Safety, Tolerability, and Pharmacokinetics of EGT710, a Novel Coronavirus Mpro Inhibitor, in Healthy Adults: A Randomized, Single‐ and Multiple‐Dose Study
Oral EGT710 (capsule and suspension) was safe and well tolerated, with pharmacokinetics that support further development as a treatment for coronavirus disease.
J. Oosterhaven, Jonathan Trolander, Lidiya Bebrevska et al.
· Clinical pharmacology in dru... · 1 citation